Deutsche Bank Maintains Buy on Edwards Lifesciences, Lowers Price Target to $85
Portfolio Pulse from Benzinga Newsdesk
Deutsche Bank analyst Pito Chickering maintains a Buy rating on Edwards Lifesciences (NYSE:EW) but lowers the price target from $103 to $85.
July 25, 2024 | 4:08 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Deutsche Bank maintains a Buy rating on Edwards Lifesciences but lowers the price target from $103 to $85, indicating a more cautious outlook.
The Buy rating suggests continued confidence in the company's long-term prospects, but the lowered price target reflects a more cautious short-term outlook. This mixed signal is likely to result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100